This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Les Laboratoires Servier. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Eva Maria Carlsen Melander: Innovator in Combination Therapies
Introduction
Eva Maria Carlsen Melander is a prominent inventor based in Malmö, Sweden. She has made significant contributions to the field of immunotherapy, particularly in the development of combination therapies targeting critical immune checkpoints.
Latest Patents
Eva holds a patent for her innovative work titled "Combination therapies targeting PD-1, TIM-3, and LAG-3." This patent relates to the use of antibodies specific for these targets in patients who require enhanced immunity. The therapies developed under this patent are particularly useful in treating diseases such as cancers.
Career Highlights
Eva is currently associated with Les Laboratoires Servier, where she continues to advance her research in immunotherapy. Her work has garnered attention for its potential to improve treatment outcomes for patients with various cancers.
Collaborations
Eva collaborates with notable colleagues, including Trine Lindsted and Michael Monrad Grandal, who contribute to her research efforts and the development of innovative therapies.
Conclusion
Eva Maria Carlsen Melander is a trailblazer in the field of combination therapies, with her patent reflecting her commitment to enhancing patient immunity and improving cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile